|
|
||||||||
Technical Briefs |
1 Division of Medical Biochemistry, Stavanger University Hospital, Stavanger, Norway;2 Agder University College, Department of Natural Sciences, Kristiansand, Norway;3 Blood Bank and 7 Center for Clinical Research, Haukeland University Hospital, Bergen, Norway;4 Cecor AS, Haugesund, Norway; 5 Elf Petroleum Stavanger AS, Stavanger, Norway;6 Norsk Hydro Aluminum, Karmøy, Norway;
aaddress correspondence to this author at: Agder University College, Department of Natural Sciences, N-4604 Kristiansand, Norway; e-mail mohammad.a.mansoor@hia.no
| The first 20% of the full text of this article appears below. |
Endothelial-cellderived nitric oxide (NO) relaxes vascular smooth muscle cells, causes vasodilation, and inhibits platelet aggregation. It has been demonstrated that NO3 is the predominant and stable form of NO present in plasma and represents the bioavailability of NO (1)(2). NO generation is depressed in blood vessels affected by atherosclerosis, and a loss of NO activity is associated with impaired vasoreactivity, enhanced platelet aggregation, and increased endothelial cellleukocyte interactions (3).
Recently, evidence has accumulated that suggests that increased concentrations of the amino acid homocysteine (Hcy) also increase the risk for cardiovascular disease (CVD) (4). Hcy concentrations can be lowered by supplementation with folate, vitamin B6, vitamin B2, and vitamin B12 (5)(6). In particular, folate may also contribute in the prevention of CVD because folate seems to restore impaired NO metabolism (7).
In the present investigation, we included apparently healthy persons. Individuals on all types of medications were excluded from this cross-sectional study. Blood samples were collected from participants who had been fasting for 12 h. The blood samples were centrifuged at 4 °C within 1 h and stored at 80 °C until analysis. Informed written consent was obtained from all participants. The study was approved by the Regional Ethics committee, University of Bergen, Norway.
Total homocysteine (tHcy) concentrations in plasma were
The following articles in journals at HighWire Press have cited this article:
![]() |
D. J. Veselik, S. Divekar, S. Dakshanamurthy, G. B. Storchan, J. M.A. Turner, K. L. Graham, L. Huang, A. Stoica, and M. B. Martin Activation of Estrogen Receptor-{alpha} by the Anion Nitrite Cancer Res., May 15, 2008; 68(10): 3950 - 3958. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |